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Abstract
The intestine is an ‘invironment’, a shared space where the interior and the exterior of the organism merge. The complexity of the
intestinal microbiome modulates such interaction, and reﬂects the coordinated evolution of animals and intestinal microbes. The intesti-
nal microbiome is exposed to the environmental resistome, to intestinal organisms from other hosts and also to microbiome-damaging
agents, such as antibiotics. The result is a ‘genetic-genomic-metagenomic reactor’ where resistance genes ﬂow among different biological
units of different hierarchical levels, such as integrons, transposons, plasmids, clones, species or genetic exchange communities. Metage-
nomics provides the possibility to explore the presence of antibiotic resistance genes in all these biological and evolutionary units, and
to identify possible ‘high risk associations’. Multi-layered metagenomic epidemiology is required to understand and eventually to predict
and apply interventions aiming to limit antibiotic resistance.
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The intestine as an ‘invironment’
The intestine is a duct crossing the deepest intimacies of
the body of humans and animals, physically open to the
external environment at both of its extremes and to the
interior of the body by a multitude of interactive sites. It
could be well deﬁned as an ‘invironment’, borrowing
Michael Bell’s expression [1], i.e. a shared space where
the interior and the exterior of organisms merge, in other
words an endogenized external environment. The intestine
concentrates the highest density of human chemical and
biological interactions with the living environment, and
such interactions are mainly represented and managed
throughout the intestinal microbiota.
The intestinal microbiota, the last organ to
be deciphered in the human body
Humans (as all other animals or plants) are not only con-
stituted by their species-speciﬁc cells. The human body is
a consortium of human and bacterial cells, and human
physiological (and may be behavioural) features are a result
of this consortium. In terms of genetic information, the
number of genes in the intestinal microbiota (more than 3
million unique genes overall) outweighs by 150 times the
number of genes in the human genome [2]. This means
that the idea of a human body that was subsequently col-
onized by microbes is simply a biological mistake. The
intestinal microbiota is a real organ, a half-external organ
of our economy. A human without its intestinal microbiota
is simply not a metabolically viable human and is an envi-
ronmentally incompatible structure prone to extinction.
What we know is that our intestinal microbiota is extre-
mely complex in terms of bacterial groups and integrated
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interactions, and such complexity is featuring the stability
and probably the reproduction of the microbiota.
Ontogeny and phylogeny of the intestinal
microbiota
Of course, as in the case of other organs, there should
be an ontogeny and a phylogeny of intestinal microbiota,
certainly a key area for future research. Starting from the
consideration of microbiotic ontologies, the ﬁrst theoreti-
cal and bioinformatic steps in this direction have been
proposed [3,4]. The anatomy and physiology of the intes-
tine in different animals, from nematodes to mammals, are
shaped by the interactions of the host with the microbi-
ota, so there is certainly a microbiota–host coevolution
that has been scarcely considered in evolution [5]. How
microbiota diversiﬁcation correlates with geographical
diversiﬁcation during evolution has also started to be
explored by studying extinct human microbiomes [6].
Where did the bacterial organisms from the intestinal mic-
robiota originate? And which are the biological rules that
apply to build up the extreme complexity of the microbi-
ota composition not only during evolutionary times but
also in each individual host? What we know is that the
intestinal microbiota is reproducible, transmitted to the
progeny and close relatives; in a sense, it multiplies itself
as a collective biological individual. As far as their possible
evolutionary origins, it is tempting to suggest that every
organism in the intestinal microbiota had an ancestor in
the environmental microbial systems, and that bacterial
communities degrading organic residues in the soil, or pro-
viding symbiotic effects in plants, might constitute ancestor
communities for the primitive intestinal microbiota in early
Enterozoa. Recent holistic approaches such as the Earth
Microbiome Project might eventually cast some light on
these points [7].
The intestinal microbiota is exposed to the
environmental resistome
The intestine is an open system, exposed to the inﬂuences
of the myriad of daily bacterial acquisitions from environ-
mental microbes, including the microbiomes of other
members of the same species, from other species and
from food, water or soil. Many members of these incom-
ing bacteria are harbouring antibiotic resistance genes. For
instance, 7% of the isolates among a sample of 480 soil
Streptomyces were able to detoxify macrolide antibiotics in
culture media [8???]. Many antibiotic resistance genes
evolve from chromosomal genes encoding housekeep-
ing functions, primarily unrelated to any antibiotic resis-
tance phenotype [9]. Metagenomic analysis of intestinal
microbiota has revealed an unexpected wealth of different
b-lactamases, most of them unknown in culturable bacte-
rial pathogens [10]. These authors found CTX-M enzymes
both in metagenomic samples and in bacterial culturable
commensal pathogens, but, unexpectedly, failed to ﬁnd in
metagenomes frequent b-lactamases present in Enterobac-
teriaceae, such as the apparently ubiquitous TEM-derived
or AmpC enzymes. At present it is difﬁcult to deduce the
physiological function of these known (e.g. CTX-M) or
unknown metagenomic b-lactamases, but of course protec-
tion of the normal commensals towards b-lactam antimi-
crobials cannot be discarded. It could be interesting to
investigate the environmental origin of these inactivating
enzymes. For instance, CTX-M enzymes are chromosomal
genes in soil–water bacteria such as Kluyvera [11].
The environmental microorganisms–
intestinal microbiota interaction
How these resistance-encoding genes enter into bacterial
species able to produce infections in humans has been a
hot topic of research during the last few years. Mobiliza-
tion, i.e. gene capture, probably occurs mainly by insertion
sequences harboured by transposons or plasmids [12]. The
process of direct acquisition of genes from environmental
bacteria by gut intestinal commensals could be constrained
by the cell density required for the transient donors. On
the other hand, antibiotic exposure might favour such
types of events to a certain extent. The risk of fusing eco-
logical compartments such as soil and human intestinal
microbiota in sewage and sludge has been pointed out.
Certainly it is difﬁcult to believe that public health ofﬁcers
and ecotoxicologists have failed for more than a century
to seriously propose the absolute need to prevent the
mix between microorganisms from human–animal and envi-
ronmental compartments [13]. In conditions of water sew-
age antibiotic contamination, the acquisition of resistance
genes might be favoured. It should be noted that, although
conventional biological wastewater treatment processes are
effective for the removal of some antibiotics, many antibi-
otics have been reported to occur at 10–1000 ng/L in sec-
ondary treated efﬂuents, including b-lactams, sulfonamides,
trimethoprim, macrolides, ﬂuoroquinolones and tetracy-
clines [14].
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Metagenomic populations of trans-
hierarchical evolutionary individuals
Metagenomics literally means ‘beyond the genome’ [15].
Metagenomics is a critical tool to study the laws of con-
version from evolutionary ‘pieces’ (evolutionary individuals)
into ‘patterns’ (selectable ensembles of individuals) [16].
A key issue in future metagenomic epidemiology is the
need to target sequences able to detect changes in evolu-
tionary individuals, ‘beyond the genome’. But what is an
evolutionary individual? An individual is both a replicator (a
reproducing entity) and a variator (let us borrow this term
from engineering and computer sciences). All entities that
reproduce and are submitted to variation are evolutionary
individuals (evolutionary units), with potential to be
hooked by natural selection. The levels of selection
approach [17] considers whether natural selection operates
on evolutionary individuals at different levels of complexity,
such as genetic sequences, genes, operons, mobile genetic
elements (MGEs) (such as plasmids or transposable ele-
ments), genomes, organisms, clones, groups, species, com-
munities or ecosystems. In this perspective, an individual is
any entity that, independently from the number of ele-
ments that enters into its composition or from its hierar-
chical complexity, is selected as a unit. The elements that
compose an individual might be in their turn individuals,
and therefore able to be selected as units. Of course,
individuals are grouped in populations. Populations are
composed of individuals, are groups of individuals linked
by common patterns of genetic (evolutionary cohesion)
and demographic (ecological cohesion) connectivity, i.e. dif-
fering by descent and spatial location from other popula-
tions [18].
Metagenomic evolutionary units involved in
antibiotic resistance
The emergence and spread of antibiotic resistance is
determined by sequences in resistance genes, but also by
the genetic structure in which these genes are placed (as
integrons) and the MGEs where these elements are able
to disseminate (such as plasmids, phages, transposons or
integrative-conjugative elements). In their turn, the mainte-
nance or spread of these MGEs depends on their localiza-
tion in clones or clonal complexes within species, but also
on the connectivity of these species with other species,
i.e. in their possible spread within genetic exchange bacte-
rial communities. The establishment and evolution of these
communities depends also on the entire microbiotic con-
text. Because of that, a multi-layered metagenomic epide-
miology approach is required to understand and eventually
to predict and apply interventions aiming to limit antibiotic
resistance. As we shall see later, such an approach is
starting to be applied in a systematic way in the study of
particular resistance problems but it remains essentially
based on culturable organisms, requires an extensive
amount of work, and probably fails to detect essential
characters in the plot. To circumvent these difﬁculties, a
metagenomic analysis is required.
Such a metagenomic analysis should take into consider-
ation the following.
1 A general metagenomic proﬁling of the abundant taxa
and species present in the microbiota. Very little is
known about how differences in large taxa–species
microbiotic proﬁles might inﬂuence antibiotic resistance,
particularly under conditions of antibiotic exposure or
in situations where full integrity of the microbiotic sys-
tem might be immature, degraded or damaged, as in
the newborns, elderly people, people with nutritional
deﬁciency, and patients with anatomical or physiological
alterations that might inﬂuence the intestinal environ-
ment.
2 The metagenomic identiﬁcation of the existence and
composition of groups of species that form genetic
exchange communities [19] where particular MGEs and
resistance genes might preferentially circulate. Note that
these communities are made up by both commensal and
potentially pathogenic strains, and are expected to be
key elements for the maintenance of antibiotic resistance
genes.
3 The metagenomic identiﬁcation of particular species
and clones of particular interest in antibiotic resistance,
mainly bacterial pathogens. If species identiﬁcation is
relatively easy (based for instance on ribosomal DNA
sequences), a more difﬁcult metagenomic task that
requires attention is the identiﬁcation of particular
clones within species, in particular the detection of so-
called ‘high risk clones or clonal complexes’, referring
to highly specialized genetic populations or subpopula-
tions with enhanced ability to colonize, spread and
persist in particular niches after having acquired a
diversity of adaptive traits that increase their epidemic-
ity and/or pathogenic potential, including antibiotic
resistance. These clones, replacing the more heteroge-
neous antibiotic-susceptible ones, become ‘ampliﬁcators’
of antimicrobial resistance [20].
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4 The identiﬁcation of the subcellular metagenomic mobi-
lome, i.e. identiﬁcation of MGEs involved in the spread
of antibiotic resistance. Of course we can apply differ-
ent observational levels. A general ‘plasmidome’ proﬁl-
ing can be followed by identiﬁcation of more precise
plasmid groups, based on Rep, Rel or TA sequences
[21]. Similarly, we need a general metagenomic proﬁl-
ing of phages, transposons and integrative-conjugative
elements, and more speciﬁc detection of the different
particular elements, for instance Tn21-type transpo-
sons. That should be complemented by a general
metagenomic proﬁling of integrons and speciﬁc detec-
tion of particular integrons.
5 Finally, a gene-based metagenomic analysis could be
focused just on sequences, genes or groups of genes,
such as operons, regulatory genes, genes or sequences
involved in the capture of other genes, including resis-
tance genes. Appropriate speciﬁc or degenerate
sequences will be able to shape the orthology of the tar-
geted genes, as detection of orthologues, homologues or
paralogues [22].
For the purposes of the main message of this work, the
important point is that these ﬁve metagenomic approaches
are applied at different levels of the microbiome complexity,
identifying distinct evolutionary individuals at each hierarchi-
cal level.
The metagenomic dynamics of
evolutionary units: the four Ps
Epidemiology shares with evolution the interest in detecting
the variations in the frequency of and tracing the changes in
the associations of the target epidemiological or evolutionary
units. Both the variations in frequency and the emerging
changes or associations in antibiotic resistance depend on
the construction of interactive networks able to exchange
resistance genes between communities, groups of species,
organisms, and/or among MGEs and their platforms. In fact
knowledge of how these changes and associations occur
might eventually offer some insights to predict evolutionary
trajectories and to apply appropriate interventions [23]. For
that purpose, the distinction of a number of key properties
applicable in every kind of evolutionary unit is needed.
At any level of the hierarchy (let us say, from clones to
plasmids or genes), the ecology and evolution of antimicro-
bial resistance depends on the ‘four Ps’: penetration, promis-
cuity, plasticity and persistence of the different genetic units
[24] (Fig. 1).
Penetration is used here, by analogy with the term used in
security engineering, for elements having a high attack proﬁle
regarding existing networks and refers to the ability of a
genetic element from a particular system to enter and be
present in other systems. Examples are bacterial clones able
to efﬁciently colonize and spread in microbiomes of different
hosts, or broad-host-range plasmids disseminating in widely
different bacteria.
Promiscuity refers to the ability not only to enter and be
present in other systems but to exchange genetic sequences
with the members of these systems.
Plasticity is applied here as tolerated variability in the
genetic sequences, from changes in the sequence of nucle-
otides in a gene, to changes in the order of genes in a
genome (syntheny) or changes in the modular structure of
genetic regions (modularity) or in the modulation of their
expression. An example of this is the change in the order
of gene cassettes within a particular integron.
Persistence is the ability for ‘niche construction’ of each
one of the biological elements, so that permanent links with
their surrounding environment (including the genetic con-
text) are established, allowing long-term coexistence or ﬁxa-
tion of the sequence or element in the system.
Metagenomics in predicting antibiotic
resistance
Prediction of the behaviour of highly complex systems is a
difﬁcult task, particularly very early (birth of a new resistance
gene, gene capture and establishment) and long-term and
global predictions (gene spread and evolution among bacte-
rial populations). In these cases, the occurrence and
Penetration Promiscuity Plasticity Persistence
FIG. 1. Universal processes in biological units. These processes are
valid for evolutionary individuals (evolutionary units) at any level of
the genetical hierarchy, from metagenomes to species, clones, mobile
genetic elements, genes or modular genetic sequences; and possibly
for operational taxonomic units, such as those that might be based
on barcoding data. Vertical rectangles represent individuals recom-
bining or associating with the horizontal rectangles.
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frequency of evolutionary events are either stochastic or
present an indescribable level of variability, so that theoreti-
cal predictions are probably impossible with our current
tools. Possible ways of approaching prediction is to work
with data obtained in experimental studies with natural pop-
ulations, or to apply multi-level genetic epidemiology in early
observations of emerging resistance [25].
In the ﬁrst case, a diversity of natural bacterial communi-
ties (such as human or animal microbiota) should be
exposed, either in vitro (microcosms) or in vivo, on the occa-
sion of clinical trials or antibiotic challenge in experimental
farms. High-throughput metagenomic screening of antibiotic-
selected bacterial groups might provide early data about the
possibilities of emergence and selection of particular resis-
tance genes, and eventually of the MGEs and bacterial groups
in which resistance is expected to occur. Of course negative
results are scarcely predictive, as experimental studies are
only possible with a limited number of samples. Surveillance
networks for early antibiotic resistance could provide more
solid predictive clues [26,27]. A multi-layered epidemiological
strategy based on metagenomics should be applied in these
studies, trying to characterize simultaneously the resistance
genes, the genetic platforms in which they are located (as
integrons), the transposable elements harbouring such
platforms, the plasmids eventually carrying them, and at
supracellular level the bacterial clones, species and communi-
ties in which the resistance gene occurs (Fig. 2). These stud-
ies are currently carried out in focused, hard work-load
studies by more conventional methods [28–30].
A certain contribution to the integrated risk of spreading
resistance might be attributed at each of these levels, but we
are far from being able to provide quantitative assessments
and hence a real prediction of resistance spread and its
future evolutionary trajectories. Heuristic techniques are
being considered for the understanding of multi-level selec-
tion in the presence or absence of antibiotics, based on
covariance, and contextual analysis, for instance using Price’s
equation [31], which might open an entirely new synthetic
way of approaching prediction of antibiotic resistance.
A metagenomic registry of evolutionary
units involved in antibiotic resistance
(EVUARS)
A natural milestone of metagenomic studies devoted to anti-
biotic resistance should be the construction of a catalogue-
repositorium, a registry of evolutionary units for antibiotic
resistance (EVUARs) from DNA sequences and genes to
microbial communities. In a ﬁrst step such a catalogue could
be based on the most immediate environment (‘invironment’,








FIG. 2. Multi-level metagenomic epidemiology. Small circles represent evolutionary individuals (evolutionary units) that constitute populations
(large circles). Arrows indicate possible evolutionary trajectories constituted by trans-hierarchical interactions between evolutionary units. High
risk interactions are those that might give rise to a particularly successful combination able to disseminate or perpetuate antibiotic resistance,
and therefore should be targeted by public health epidemiology.
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before, antibiotic resistance is also an ecological problem,
inﬂuenced by alterations in the global environment [32]. This
approach requires (i) a collection of EVUAR proﬁles in dif-
ferent locations, from the intestine of humans and animals to
sludge, sewage or soil under different selective or environ-
mental conditions (antibiotic exposure, industrial residues
exposure, climate); (ii) a collection of EVUAR association
patterns—how different evolutionary units associate statisti-
cally and how these associations evolve in time; (iii) the
study of the conditions that might explain these covariances;
and (iv) in silico, in vitro and in vivo modelization procedures
to reproduce the observed associations. These studies might
follow, at least in part, preceding initiatives about ‘registries
of standard biological parts’ that are starting to be used in
synthetic biology research [33,34].
Metagenomics for surveillance and
intervention: eco-evo approaches
The evolutionary units involved in antibiotic resistance that
metagenomic studies might reveal are in fact the natural
units for surveillance of antibiotic resistance. Surveillance
should be applied for changes in the frequency of the
units, and particularly for changes in the correlated fre-
quency of the units or evolutionary individuals, considering
the different hierarchical levels of biological complexity.
Such changes might reveal dangerous evolutionary ensem-
bles moving along high risk evolutionary trajectories. Of
course speciﬁc interventions could be designed targeting
speciﬁc key elements involved in these processes. The
need of focused research to ﬁnd drugs and strategies aim-
ing to counteract the above-mentioned ‘four Ps’, penetra-
tion, promiscuity, plasticity and persistence of evolutionary
units such as bacterial clones, MGEs or resistance genes,
has recently been suggested [24]. The term ‘drug’ is used
in this eco-evo perspective as a tool to ﬁght resistance
that is able to prevent, cure or decrease potential damage
caused by antibiotic resistance, not necessarily only at the
individual level (the patient) but also at the ecological and
evolutionary levels. Eco-evo drugs and interventions consti-
tute a new avenue for research that might inﬂuence not
only antibiotic resistance but the maintenance of a healthy
interaction between humans and microbial systems in a
rapidly changing environment. Such an ambitious approach
will be unimaginable in the absence of metagenomics, but
its consequences might provide the tools for shaping and
correcting the undesirable deviations of the microbio-
sphere and their perverse consequences for human and
Earth health, as the novel perspectives in ‘one health—one
medicine’ and consequently in advanced public health
microbiology require [35,36].
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